收藏切换
Individualized Dosing Regimens of Teicoplanin for Patients with Hypoalbuminemia Based on Population Pharmacokinetics
收藏切换
Jianpeng HE1, 2, Chen YE1, Ying WANG1, Zhanhua HU1, Zeyuan HE1, Yuqing CHEN1, Guocheng LI1, Min HUANG2, Xiaoxia YU1, *
Pharmacy Today | 2026, 36(4) : 308 - 314
Less
收藏切换
Pharmacy Today | 2026, 36(4): 308-314
Individualized Dosing Regimens of Teicoplanin for Patients with Hypoalbuminemia Based on Population Pharmacokinetics
Full
Jianpeng HE1, 2, Chen YE1, Ying WANG1, Zhanhua HU1, Zeyuan HE1, Yuqing CHEN1, Guocheng LI1, Min HUANG2, Xiaoxia YU1, *
Affiliations
  • 1.Department of Pharmacy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China
  • 2.School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China
Published: 2026-04-25 doi: 10.12048/j.issn.1674-229X.2026.04.010
Outline
收藏切换
OBJECTIVE

To characterize the pharmacokinetic characteristics of teicoplanin in patients with hypoalbuminemia, explore the target values of pharmacokinetic/pharmacodynamic (PK/PD) parameters, and develop individualized dosing regimens.

METHODS

Clinical data of patients with hypoalbuminemia were retrospectively collected, and a population pharmacokinetic analysis was performed using a nonlinear mixed-effects model. Classification and regression tree (CART) analysis and survival analysis were used to explore and verify the impact of the target values of (PK/PD) parameters on therapeutic efficacy. Monte Carlo simulation was applied to develop individualized dosing regimens.

RESULTS

A one-compartment population pharmacokinetic model of teicoplanin was established using 328 blood concentration values from 195 patients. The population typical values of clearance and apparent volume of distribution of the model were 0.612 L·h-1 and 91.2 L, respectively. Estimated glomerular filtration rate (eGFR) was included as a covariate for clearance, and albumin and urea were included as covariates for the apparent volume of distribution. The target values of PK/PD parameters were determined as trough concentration ≥15 mg·L-1 and the ratio of 24 hour area under the drug-time curve to minimum inhibitory concentration (AUC24/MIC)≥790. Several individualized dosing regimens were developed based on different levels of the model covariates.

CONCLUSION

For patients with hypoalbuminemia receiving teicoplanin, it is necessary to increase the dosage and frequency of the loading dose regimen according to the patients' albumin and eGFR levels, and adjust the maintenance dose regimen according to the MIC of pathogenic bacteria, so as to improve clinical efficacy.

teicoplanin  /  hypoalbuminemia  /  population pharmacokinetics  /  pharmacokinetic/pharmacodynamic (PK/PD) parameters  /  individualized dosing regimens
何健鹏, 叶晨, 王莹, 胡展华, 何泽源, 陈雨晴, 李国成, 黄民, 余晓霞. 基于群体药动学的替考拉宁在低白蛋白血症患者中的个体化用药研究. 今日药学, 2026 , 36 (4) : 308 -314 . DOI: 10.12048/j.issn.1674-229X.2026.04.010
Jianpeng HE, Chen YE, Ying WANG, Zhanhua HU, Zeyuan HE, Yuqing CHEN, Guocheng LI, Min HUANG, Xiaoxia YU. Individualized Dosing Regimens of Teicoplanin for Patients with Hypoalbuminemia Based on Population Pharmacokinetics[J]. Pharmacy Today, 2026 , 36 (4) : 308 -314 . DOI: 10.12048/j.issn.1674-229X.2026.04.010
Year 2026 volume 36 Issue 4
115
27
Cite this Article
BibTeX
Article Info
doi: 10.12048/j.issn.1674-229X.2026.04.010
  • Receive Date:2026-02-06
  • Online Date:2026-09-23
  • Published:2026-04-25
Article Data
Affiliations
History
  • Received:2026-02-06
Funding
Affiliations
    1.Department of Pharmacy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China
    2.School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510006, China
References
Share
https://castjournals.cast.org.cn/joweb/jryx/EN/10.12048/j.issn.1674-229X.2026.04.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT